Genialis
Signal active
Organization
Contact Information
Overview
Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. It engages in unraveling complex biology to find new ways to address disease. Its platform defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development.
Genialis was established in 2015 in Boston, Massachusetts by Rafael Rosengarten.
About
Industries
Biotechnology, Health Care, Medical, Bioinformatics, Precision Medicine
Founded
2015
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Genialis headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Bioinformatics, Precision Medicine sector. The company focuses on Biotechnology and has secured $1.2B in funding across 80 round(s). With a team of 11-50 employees, Genialis is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Genialis, raised $134.8K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$15.5M
Details
2
Genialis has raised a total of $15.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Seed | 2.3M | ||
| 2023 | Early Stage Venture | 13.0M |
Investors
Genialis is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Debiopharm Innovation Fund | - | FUNDING ROUND - Debiopharm Innovation Fund | 13.0M |
| P5 Health Ventures | - | FUNDING ROUND - P5 Health Ventures | 13.0M |
| Genialis | - | FUNDING ROUND - Genialis | 13.0M |
| redalpine | - | FUNDING ROUND - redalpine | 13.0M |
Recent Activity
There is no recent news or activity for this profile.